Back

Dual therapy, triple therapy, or single-pill combination: still underused or already part of physicians' mindsets?

29 August 2021 (13:02 - 13:15)
Organised by:
Congress Presentation Part of: Single-pill combinations (SPCs) first line in ESC/ESH 2018 guidelines for hypertensive patients: where do we stand 3 years later? Hypertension Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Atul Pathak

Institut de Chirurgie Cardiaque et de Cardiologie Interventionnelle, Luxembourg (Luxembourg)

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor A. Januszewicz (Warsaw, PL)
Slides Video
Presentation thumbnail
Following current guidelines, and beyond, Single-pill combinations (SPC) is a way to improve patient care in hypertension.
Doctor O. Rotar (Saint Petersburg, RU)
Video
Presentation thumbnail
Discussion.
Video
Presentation thumbnail
Conclusion.
Professor K. Tsioufis (Athens, GR)
Video

Access the full session

Session thumbnail
Single-pill combinations (SPCs) first line in ESC/ESH 2018 guidelines for hypertensive patients: where do we stand 3 years later?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 13:02 CET
You may be interested in
thumbnail
Congress Presentation
Early use of triple single pill combination: make it a habit
30 August 2025
thumbnail
Congress Presentation
Portuguese experience with dual and triple therapy in atrial fibrillation and acute coronary syndrome patients
29 June 2021
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources